Agency Information Collection Activities: Proposed Collection; Comment Request, 63655-63657 [2019-24930]
Download as PDF
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Notices
Skeie-Campbell as trustee, both of
Corrales, New Mexico; to be approved as
members acting in concert with the
Skeie Family Control Group to retain
voting shares of Financial Services of
Winger, Inc., and thereby indirectly
retain voting shares of Ultima Bank
Minnesota, both of Winger, Minnesota.
Board of Governors of the Federal Reserve
System, November 13, 2019.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2019–24969 Filed 11–14–19; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier CMS–10260, CMS–R–
297/CMS–L564, CMS–4040, CMS–10718 and
CMS–10146]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
January 17, 2020.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
SUMMARY:
VerDate Sep<11>2014
17:41 Nov 15, 2019
Jkt 250001
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number ___, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
https://www.cms.gov/Regulations-andGuidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10260 Medicare Advantage and
Prescription Drug Program: Final
Marketing Provisions in 42 CFR
422.111(a)(3) and 423.128(a)(3)
CMS–R–297/CMS–L564 Request for
Employment Information
CMS–4040 Request for Enrollment in
Supplementary Medical Insurance
(SMI) and Supporting Regulations
in 42 CFR 407.10, 407.11 and
408.40(a)(2)
CMS–10718 Model Medicare
Advantage and Medicare
Prescription Drug Plan Individual
Enrollment Request Form
CMS–10146 Notice of Denial of
Medicare Prescription Drug
Coverage
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
63655
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Revision with change of a
currently approved collection; Title of
Information Collection: Medicare
Advantage and Prescription Drug
Program: Final Marketing Provisions in
42 CFR 422.111(a)(3) and 423.128(a)(3);
Use: Pursuant to disclosure
requirements set out in sections
1851(d)(2)(A) and 1860D–1(c) of the
Social Security Act (the Act), and cited
in §§ 422.111(a)(3) and 423.128(a)(3),
Medicare Advantage (MA) organizations
and Part D sponsors must provide notice
to plan members of impending changes
to plan benefits, premiums and cost
sharing in the coming year. To this
effect, members will be in the best
position to make an informed choice on
continued enrollment or disenrollment
from that plan at least 15 days before the
Annual Election Period (AEP) using the
Annual Notice of Change (ANOC) and
before the first day of the AEP for the
Evidence of Coverage (EOC). MA
organizations and Part D sponsors must
notify plan members of the coming year
changes using the standardized ANOC.
Plans must disseminate the EOC at the
time of enrollment and at least annually
thereafter.
CMS requires MA organizations and
Part D sponsors to use the standardized
documents being submitted for OMB
approval to satisfy disclosure
requirements mandated by section
1851(d)(3)(A) of the Act and § 422.111
for MA organizations and section
1860D–1(c) of the Act and
§ 423.128(a)(3) for Part D sponsors.
Sections 1851(h)(1) and (2) of the Act
require MA organizations and Part D
sponsors to obtain CMS approval of
marketing materials to ensure that MA
organizations and Part D sponsors
disclose correct information to current
and potential enrollees. CMS collects
and retains the MA organization and
Part D plan marketing materials via the
Health Plan Management System
E:\FR\FM\18NON1.SGM
18NON1
63656
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Notices
(HPMS). MA organizations and Part D
plans submit marketing materials to the
CMS marketing material review process
using HPMS. Both current and potential
enrollees can review other marketing
materials to find plan benefits,
premiums, and cost sharing for the
coming year (after October 1) and the
current year to be in a better position to
make.
MA organizations and Part D sponsors
use the information discussed in the
Medicare Communication and
Marketing Guidelines (MCMG) to
comply with the requirements to seek
CMS approval on marketing materials
under MA and Part D law and
regulations, as described above. CMS
requires MA organizations and Part D
sponsors to obtain CMS approval of
marketing materials to ensure that MA
organizations and Part D sponsors
disclose correct information to current
and potential enrollees. Both current
and potential enrollees can review other
marketing materials to find plan
benefits, premiums, and cost sharing for
the coming year (after October 1) and
the current year to be in a better
position to make informed and educated
plan selections. Form Number: CMS–
10260 (OMB control number: 0938–
1051); Frequency: Yearly; Affected
Public: State, Local, or Tribal
Governments; Number of Respondents:
795; Total Annual Responses: 47,962;
Total Annual Hours: 33,124. (For policy
questions regarding this collection
contact Timothy Roe at (410) 786–2006.)
2. Type of Information Collection
Request: Extension without change of a
currently approved collection; Title of
Information Collection: Request for
Employment Information; Use: The form
CMS–L564, also referred to as CMS–R–
297, is used, in conjunction with form
CMS–40–B, Application for
Supplementary Medical Insurance,
during an individual’s special
enrollment period (SEP). Completed by
an employer, the CMS–L564 provides
proof of an applicant’s employer group
health coverage. The Social Security
Administration (SSA) uses it to obtain
information from employers regarding
whether a Medicare beneficiary’s
coverage under a group health plan is
based on current employment status.
This form is available in both English
and Spanish.
Section 1837(i) of the Social Security
Act (the Act) provides a SEP for
individuals who delay enrolling in
Medicare Part B because they are
covered by a group health plan based on
their own or a spouse’s current
employment status. Disabled
individuals with Medicare may also
delay enrollment because they have
VerDate Sep<11>2014
17:41 Nov 15, 2019
Jkt 250001
large group health plan coverage based
on their own or a family member’s
current employment status. When these
individuals apply for Medicare Part B,
they must provide proof that the group
health plan coverage is (or was) based
on current employment status. Form
CMS L564 provides this proof so that
SSA can determine eligibility for the
SEP. Individuals eligible for the SEP can
enroll in Part B without incurring a late
enrollment penalty. Individuals may
also use this form to prove that their
group health plan coverage is based on
current employment status and to have
the assessed Medicare late enrollment
penalty reduced.
The form is available online via
Medicare.gov and CMS.gov for
individuals who are requesting the SEP
to obtain and submit to their employer
for completion. The employer must
complete and sign the form, and submit
it to the individual to accompany their
enrollment or late enrollment penalty
reduction request. The information on
the completed form is reviewed
manually by SSA. Thus, the collection
of this information does not involve the
use of information technology. Form
Number: CMS–R–297/CMS–L564 (OMB
control number: 0938–0787); Frequency:
Yearly; Affected Public: State, Local, or
Tribal Governments; Number of
Respondents: 15,000; Total Annual
Responses: 15,000; Total Annual Hours:
1,250. (For policy questions regarding
this collection contact Carla D.
Patterson, at (410) 786–1000.)
3. Type of Information Collection
Request: Extension without change of a
currently approved collection; Title of
Information Collection: Request for
Enrollment in Supplementary Medical
Insurance (SMI) and Supporting
Regulations in 42 CFR 407.10, 407.11
and 408.40(a)(2); Use: Section 1836 of
the Social Security Act, and CMS
regulations at 42 CFR 407.10, provide
the eligibility requirements for
enrollment in Part B for individuals age
65 and older who are not entitled to
premium-free Part A. The individual
must be a resident of the United States,
and either a U.S. Citizen or an alien
lawfully admitted for permanent
residence that has lived in the US
continually for 5 years.
CMS regulations 42 CFR 407.11 lists
the CMS–4040 as the application to be
used by individuals who are not eligible
for monthly Social Security/Railroad
Retirement Board benefits or free Part A.
The CMS–4040 solicits the
information that is used to determine
entitlement for individuals who meet
the requirements in section 1836 as well
as the entitlement of the applicant or
their spouses to an annuity paid by
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
OPM for premium deduction purposes.
The application follows the application
questions and requirements used by
SSA. This is done not only for
consistency purposes but to comply
with other Title II and Title XVIII
requirements because eligibility to Title
II benefits and free Part A under Title
XVIII must be ruled out in order to
qualify for enrollment in Part B only.
Form Number: CMS–4040 (OMB control
number: 0938–0245); Frequency: Yearly;
Affected Public: State, Local, or Tribal
Governments; Number of Respondents:
29,663; Total Annual Responses:
29,663; Total Annual Hours: 7,416
hours. (For policy questions regarding
this collection contact Carla D.
Patterson, at (410) 786–1000.)
4. Type of Information Collection
Request: New collection (Request for a
new OMB control number); Title of
Information Collection: Model Medicare
Advantage and Medicare Prescription
Drug Plan Individual Enrollment
Request Form; Use: This information
collection is necessary for the Medicare
beneficiary (or their legal
representative), to enroll in an MA or
PDP plan, even if switching plans
within the same MA or PDP
organization. To consider an election
complete, the individual must:
• Complete an enrollment request;
• Provide required information to the
MA or PDP organization within the
required time frames;
• Submit the completed request to the
MA or PDP organization during a valid
enrollment period.
MA and PDP organizations,
applicants to MA and PDP
organizations, and the CMS will use the
information collected to comply with
the eligibility and enrollment
requirements for Medicare Part C and
Part D plans.
Section 4001 of the Balanced Budget
Act of 1997 (BBA) (Pub. L. 105–33)
enacted August 5, 1997, established Part
C of the Medicare program, known as
the Medicare + Choice program, (now
referred to as Medicare Advantage
(MA)). As required by 42 CFR
422.50(a)(5), an MA-eligible individual
who meets the eligibility requirements
for enrollment into an MA or MAPD
plan may enroll during the enrollment
periods specified in § 422.62, by
completing an enrollment form with the
MA organization or enrolling through
other mechanisms that the Centers for
Medicare & Medicaid Services (CMS)
determines are appropriate.
Section 101 of Title I of the Medicare
Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA) (Pub.
L. 108–173) enacted December 8, 2003,
established Part D of the Medicare
E:\FR\FM\18NON1.SGM
18NON1
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Notices
program, known as the Voluntary
Prescription Drug Benefit Program. As
required by 42 CFR 423.32(a) and (b), a
Part D-eligible individual who wishes to
enroll in a Medicare prescription drug
plan (PDP) may enroll during the
enrollment periods specified in
§ 423.38, by completing an enrollment
form with the PDP, or enrolling through
other mechanisms CMS determines are
appropriate. Form Number: CMS–10718
(OMB control number: 0938–New);
Frequency: Yearly; Affected Public:
State, Local, or Tribal Governments;
Number of Respondents: 14,749,256;
Total Annual Responses: 14,749,256;
Total Annual Hours: 10,324,481. (For
policy questions regarding this
collection contact Deme Umo at (410)
786–8854.)
5. Type of Information Collection
Request: Revision with change of a
currently approved collection; Title of
Information Collection: Notice of Denial
of Medicare Prescription Drug Coverage;
Use: The purpose of this notice is to
provide information to enrollees when
prescription drug coverage has been
denied, in whole or in part, by their Part
D plans. The notice must be readable,
understandable, and state the specific
reasons for the denial. The notice must
also remind enrollees about their rights
and protections related to requests for
prescription drug coverage and include
an explanation of both the standard and
expedited redetermination processes
and the rest of the appeal process.
CMS requests approval of changes to
a currently approved collection under
section 1860D–4(g)(1) of the Social
Security Act which requires Part D plan
sponsors that deny prescription drug
coverage to provide a written notice of
the denial to the enrollee. The written
notice must include a statement, in
understandable language, of the reasons
for the denial and a description of the
appeals process.
Medicare beneficiaries who are
enrolled in a Part D plan will be
informed of adverse decisions related to
their prescription drug coverage and
their right to appeal these decisions.
The notice provides all ways that the
beneficiary can file an appeal under one
section. The Part D instructions have
also been revised to include a paragraph
informing providers that in the case that
a request for a coverage determination is
denied under Part B due to step therapy
requirements, a different notice should
be given.
This denial notice is primarily issued
to Part D plan enrollees (Medicare
beneficiaries) and is most commonly
sent to enrollees by mail. Relying on
electronic transmission of this notice to
beneficiaries is impractical. Plans are
VerDate Sep<11>2014
17:41 Nov 15, 2019
Jkt 250001
required by regulation to maintain a
website by which beneficiaries can
request an appeal. In this version of the
notice, website information is more
prominently displayed. Form Number:
CMS–10146 (OMB control number:
0938–0976); Frequency: Yearly; Affected
Public: State, Local, or Tribal
Governments; Number of Respondents:
525; Total Annual Responses:
2,887,866; Total Annual Hours: 721,967.
(For policy questions regarding this
collection contact Sara Klotz at (410)
786–1984.)
63657
1. On page 56193, second column,
third full paragraph, last line, the email
address ‘‘Leah.Cromwell@cms.hhs.gov’’
is corrected to read ‘‘Leah.Cromwell1@
cms.hhs.gov’’.
Dated: November 4, 2019.
Kate Goodrich.
Director, Center for Clinical Standards and
Quality, Chief Medical Officer, Centers for
Medicare & Medicaid Services.
[FR Doc. 2019–24934 Filed 11–15–19; 8:45 am]
BILLING CODE 4120–01–P
Dated: November 13, 2019.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2019–24930 Filed 11–15–19; 8:45 am]
BILLING CODE 4120–01–P
[Document Identifier CMS–10611, CMS–R–
282 and CMS–R–235]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare & Medicaid
Services
[CMS–3392–CN]
Medicare Program; Request for
Nominations for Members for the
Medicare Evidence Development &
Coverage Advisory Committee;
Correction
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Correction notice.
AGENCY:
This document corrects a
typographical error that appeared in the
notice published in the Federal Register
on October 21, 2019 entitled ‘‘Request
for Nominations for Members for the
Medicare Evidence Development &
Coverage Advisory Committee.’’
DATES: This correcting document is
effective on November 15, 2019.
FOR FURTHER INFORMATION CONTACT:
Leah Cromwell, (410) 786–2243.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background and Summary of Errors
In FR Doc. 2019–22947 of October 21,
2019 (84 FR 56193), there was a
typographical error that is identified in
the FOR FURTHER INFORMATION CONTACT
section.
On page 56193, we inadvertently
made a typographical error in the email
address of the Medicare Evidence
Development & Coverage Advisory
Committee (MEDCAC) coordinator.
II. Correction of Errors
In FR Doc. 2019–22947 of October 21,
2019 (84 FR 56193), make the following
corrections:
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Centers for Medicare & Medicaid
Services
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
SUMMARY:
Comments on the collection(s) of
information must be received by the
OMB desk officer by December 18, 2019.
ADDRESSES: When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
DATES:
E:\FR\FM\18NON1.SGM
18NON1
Agencies
[Federal Register Volume 84, Number 222 (Monday, November 18, 2019)]
[Notices]
[Pages 63655-63657]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24930]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier CMS-10260, CMS-R-297/CMS-L564, CMS-4040, CMS-10718
and CMS-10146]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (the PRA), federal agencies are required to publish notice
in the Federal Register concerning each proposed collection of
information (including each proposed extension or reinstatement of an
existing collection of information) and to allow 60 days for public
comment on the proposed action. Interested persons are invited to send
comments regarding our burden estimates or any other aspect of this
collection of information, including the necessity and utility of the
proposed information collection for the proper performance of the
agency's functions, the accuracy of the estimated burden, ways to
enhance the quality, utility, and clarity of the information to be
collected, and the use of automated collection techniques or other
forms of information technology to minimize the information collection
burden.
DATES: Comments must be received by January 17, 2020.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number ___, Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, you may make
your request using one of following:
1. Access CMS' website address at https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.html.
2. Email your request, including your address, phone number, OMB
number, and CMS document identifier, to [email protected].
3. Call the Reports Clearance Office at (410) 786-1326.
FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS-10260 Medicare Advantage and Prescription Drug Program: Final
Marketing Provisions in 42 CFR 422.111(a)(3) and 423.128(a)(3)
CMS-R-297/CMS-L564 Request for Employment Information
CMS-4040 Request for Enrollment in Supplementary Medical Insurance
(SMI) and Supporting Regulations in 42 CFR 407.10, 407.11 and
408.40(a)(2)
CMS-10718 Model Medicare Advantage and Medicare Prescription Drug Plan
Individual Enrollment Request Form
CMS-10146 Notice of Denial of Medicare Prescription Drug Coverage
Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA requires federal agencies
to publish a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
or reinstatement of an existing collection of information, before
submitting the collection to OMB for approval. To comply with this
requirement, CMS is publishing this notice.
Information Collection
1. Type of Information Collection Request: Revision with change of
a currently approved collection; Title of Information Collection:
Medicare Advantage and Prescription Drug Program: Final Marketing
Provisions in 42 CFR 422.111(a)(3) and 423.128(a)(3); Use: Pursuant to
disclosure requirements set out in sections 1851(d)(2)(A) and 1860D-
1(c) of the Social Security Act (the Act), and cited in Sec. Sec.
422.111(a)(3) and 423.128(a)(3), Medicare Advantage (MA) organizations
and Part D sponsors must provide notice to plan members of impending
changes to plan benefits, premiums and cost sharing in the coming year.
To this effect, members will be in the best position to make an
informed choice on continued enrollment or disenrollment from that plan
at least 15 days before the Annual Election Period (AEP) using the
Annual Notice of Change (ANOC) and before the first day of the AEP for
the Evidence of Coverage (EOC). MA organizations and Part D sponsors
must notify plan members of the coming year changes using the
standardized ANOC. Plans must disseminate the EOC at the time of
enrollment and at least annually thereafter.
CMS requires MA organizations and Part D sponsors to use the
standardized documents being submitted for OMB approval to satisfy
disclosure requirements mandated by section 1851(d)(3)(A) of the Act
and Sec. 422.111 for MA organizations and section 1860D-1(c) of the
Act and Sec. 423.128(a)(3) for Part D sponsors.
Sections 1851(h)(1) and (2) of the Act require MA organizations and
Part D sponsors to obtain CMS approval of marketing materials to ensure
that MA organizations and Part D sponsors disclose correct information
to current and potential enrollees. CMS collects and retains the MA
organization and Part D plan marketing materials via the Health Plan
Management System
[[Page 63656]]
(HPMS). MA organizations and Part D plans submit marketing materials to
the CMS marketing material review process using HPMS. Both current and
potential enrollees can review other marketing materials to find plan
benefits, premiums, and cost sharing for the coming year (after October
1) and the current year to be in a better position to make.
MA organizations and Part D sponsors use the information discussed
in the Medicare Communication and Marketing Guidelines (MCMG) to comply
with the requirements to seek CMS approval on marketing materials under
MA and Part D law and regulations, as described above. CMS requires MA
organizations and Part D sponsors to obtain CMS approval of marketing
materials to ensure that MA organizations and Part D sponsors disclose
correct information to current and potential enrollees. Both current
and potential enrollees can review other marketing materials to find
plan benefits, premiums, and cost sharing for the coming year (after
October 1) and the current year to be in a better position to make
informed and educated plan selections. Form Number: CMS-10260 (OMB
control number: 0938-1051); Frequency: Yearly; Affected Public: State,
Local, or Tribal Governments; Number of Respondents: 795; Total Annual
Responses: 47,962; Total Annual Hours: 33,124. (For policy questions
regarding this collection contact Timothy Roe at (410) 786-2006.)
2. Type of Information Collection Request: Extension without change
of a currently approved collection; Title of Information Collection:
Request for Employment Information; Use: The form CMS-L564, also
referred to as CMS-R-297, is used, in conjunction with form CMS-40-B,
Application for Supplementary Medical Insurance, during an individual's
special enrollment period (SEP). Completed by an employer, the CMS-L564
provides proof of an applicant's employer group health coverage. The
Social Security Administration (SSA) uses it to obtain information from
employers regarding whether a Medicare beneficiary's coverage under a
group health plan is based on current employment status. This form is
available in both English and Spanish.
Section 1837(i) of the Social Security Act (the Act) provides a SEP
for individuals who delay enrolling in Medicare Part B because they are
covered by a group health plan based on their own or a spouse's current
employment status. Disabled individuals with Medicare may also delay
enrollment because they have large group health plan coverage based on
their own or a family member's current employment status. When these
individuals apply for Medicare Part B, they must provide proof that the
group health plan coverage is (or was) based on current employment
status. Form CMS L564 provides this proof so that SSA can determine
eligibility for the SEP. Individuals eligible for the SEP can enroll in
Part B without incurring a late enrollment penalty. Individuals may
also use this form to prove that their group health plan coverage is
based on current employment status and to have the assessed Medicare
late enrollment penalty reduced.
The form is available online via Medicare.gov and CMS.gov for
individuals who are requesting the SEP to obtain and submit to their
employer for completion. The employer must complete and sign the form,
and submit it to the individual to accompany their enrollment or late
enrollment penalty reduction request. The information on the completed
form is reviewed manually by SSA. Thus, the collection of this
information does not involve the use of information technology. Form
Number: CMS-R-297/CMS-L564 (OMB control number: 0938-0787); Frequency:
Yearly; Affected Public: State, Local, or Tribal Governments; Number of
Respondents: 15,000; Total Annual Responses: 15,000; Total Annual
Hours: 1,250. (For policy questions regarding this collection contact
Carla D. Patterson, at (410) 786-1000.)
3. Type of Information Collection Request: Extension without change
of a currently approved collection; Title of Information Collection:
Request for Enrollment in Supplementary Medical Insurance (SMI) and
Supporting Regulations in 42 CFR 407.10, 407.11 and 408.40(a)(2); Use:
Section 1836 of the Social Security Act, and CMS regulations at 42 CFR
407.10, provide the eligibility requirements for enrollment in Part B
for individuals age 65 and older who are not entitled to premium-free
Part A. The individual must be a resident of the United States, and
either a U.S. Citizen or an alien lawfully admitted for permanent
residence that has lived in the US continually for 5 years.
CMS regulations 42 CFR 407.11 lists the CMS-4040 as the application
to be used by individuals who are not eligible for monthly Social
Security/Railroad Retirement Board benefits or free Part A.
The CMS-4040 solicits the information that is used to determine
entitlement for individuals who meet the requirements in section 1836
as well as the entitlement of the applicant or their spouses to an
annuity paid by OPM for premium deduction purposes. The application
follows the application questions and requirements used by SSA. This is
done not only for consistency purposes but to comply with other Title
II and Title XVIII requirements because eligibility to Title II
benefits and free Part A under Title XVIII must be ruled out in order
to qualify for enrollment in Part B only. Form Number: CMS-4040 (OMB
control number: 0938-0245); Frequency: Yearly; Affected Public: State,
Local, or Tribal Governments; Number of Respondents: 29,663; Total
Annual Responses: 29,663; Total Annual Hours: 7,416 hours. (For policy
questions regarding this collection contact Carla D. Patterson, at
(410) 786-1000.)
4. Type of Information Collection Request: New collection (Request
for a new OMB control number); Title of Information Collection: Model
Medicare Advantage and Medicare Prescription Drug Plan Individual
Enrollment Request Form; Use: This information collection is necessary
for the Medicare beneficiary (or their legal representative), to enroll
in an MA or PDP plan, even if switching plans within the same MA or PDP
organization. To consider an election complete, the individual must:
Complete an enrollment request;
Provide required information to the MA or PDP organization
within the required time frames;
Submit the completed request to the MA or PDP organization
during a valid enrollment period.
MA and PDP organizations, applicants to MA and PDP organizations,
and the CMS will use the information collected to comply with the
eligibility and enrollment requirements for Medicare Part C and Part D
plans.
Section 4001 of the Balanced Budget Act of 1997 (BBA) (Pub. L. 105-
33) enacted August 5, 1997, established Part C of the Medicare program,
known as the Medicare + Choice program, (now referred to as Medicare
Advantage (MA)). As required by 42 CFR 422.50(a)(5), an MA-eligible
individual who meets the eligibility requirements for enrollment into
an MA or MAPD plan may enroll during the enrollment periods specified
in Sec. 422.62, by completing an enrollment form with the MA
organization or enrolling through other mechanisms that the Centers for
Medicare & Medicaid Services (CMS) determines are appropriate.
Section 101 of Title I of the Medicare Prescription Drug,
Improvement, and Modernization Act of 2003 (MMA) (Pub. L. 108-173)
enacted December 8, 2003, established Part D of the Medicare
[[Page 63657]]
program, known as the Voluntary Prescription Drug Benefit Program. As
required by 42 CFR 423.32(a) and (b), a Part D-eligible individual who
wishes to enroll in a Medicare prescription drug plan (PDP) may enroll
during the enrollment periods specified in Sec. 423.38, by completing
an enrollment form with the PDP, or enrolling through other mechanisms
CMS determines are appropriate. Form Number: CMS-10718 (OMB control
number: 0938-New); Frequency: Yearly; Affected Public: State, Local, or
Tribal Governments; Number of Respondents: 14,749,256; Total Annual
Responses: 14,749,256; Total Annual Hours: 10,324,481. (For policy
questions regarding this collection contact Deme Umo at (410) 786-
8854.)
5. Type of Information Collection Request: Revision with change of
a currently approved collection; Title of Information Collection:
Notice of Denial of Medicare Prescription Drug Coverage; Use: The
purpose of this notice is to provide information to enrollees when
prescription drug coverage has been denied, in whole or in part, by
their Part D plans. The notice must be readable, understandable, and
state the specific reasons for the denial. The notice must also remind
enrollees about their rights and protections related to requests for
prescription drug coverage and include an explanation of both the
standard and expedited redetermination processes and the rest of the
appeal process.
CMS requests approval of changes to a currently approved collection
under section 1860D-4(g)(1) of the Social Security Act which requires
Part D plan sponsors that deny prescription drug coverage to provide a
written notice of the denial to the enrollee. The written notice must
include a statement, in understandable language, of the reasons for the
denial and a description of the appeals process.
Medicare beneficiaries who are enrolled in a Part D plan will be
informed of adverse decisions related to their prescription drug
coverage and their right to appeal these decisions. The notice provides
all ways that the beneficiary can file an appeal under one section. The
Part D instructions have also been revised to include a paragraph
informing providers that in the case that a request for a coverage
determination is denied under Part B due to step therapy requirements,
a different notice should be given.
This denial notice is primarily issued to Part D plan enrollees
(Medicare beneficiaries) and is most commonly sent to enrollees by
mail. Relying on electronic transmission of this notice to
beneficiaries is impractical. Plans are required by regulation to
maintain a website by which beneficiaries can request an appeal. In
this version of the notice, website information is more prominently
displayed. Form Number: CMS-10146 (OMB control number: 0938-0976);
Frequency: Yearly; Affected Public: State, Local, or Tribal
Governments; Number of Respondents: 525; Total Annual Responses:
2,887,866; Total Annual Hours: 721,967. (For policy questions regarding
this collection contact Sara Klotz at (410) 786-1984.)
Dated: November 13, 2019.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2019-24930 Filed 11-15-19; 8:45 am]
BILLING CODE 4120-01-P